| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 69 |
| 1 | ESTRADIOL GEL 0.1% | 40 |
| 2 | ESTRADIOL TRANSDERMAL | 40 |
| 3 | ESTRADIOL, | 40 |
| 4 | METHYLPHENIDATE | 29 |
| 5 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 12 |
| 6 | ERGOCALCIFEROL | 11 |
| 7 | BUPRENORPHINE | 10 |
| 8 | PROGESTERONE | 10 |
| 9 | TESTOSTERONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIMONENE | 1 | 0.0909 |
| 1 | TESTOSTERONE GEL, 1% | 2 | 0.0078 |
| 2 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| 3 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 12 | 0.0029 |
| 4 | CICLOPIROX OLAMINE | 1 | 0.0021 |
| 5 | ESTRADIOL AND LEVONORGESTREL | 4 | 0.0019 |
| 6 | ESTRADIOL ACETATE | 1 | 0.0013 |
| 7 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 8 | ESTRADIOL TRANSDERMAL | 40 | 0.0009 |
| 9 | ESTRADIOL | 69 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 75 |
| 1 | Central Nervous System Stimulant [EPC] | 32 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 3 | Androgen [EPC] | 12 |
| 4 | Opioid Agonist [EPC] | 11 |
| 5 | Provitamin D2 Compound [EPC] | 11 |
| 6 | Partial Opioid Agonist [EPC] | 10 |
| 7 | Progesterone [EPC] | 10 |
| 8 | Corticosteroid [EPC] | 9 |
| 9 | Benzodiazepine [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 12 | 0.0004 |
| 1 | Progesterone [EPC] | 10 | 0.0004 |
| 2 | Estrogen [EPC] | 75 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 4 | Central Nervous System Stimulant [EPC] | 32 | 0.0004 |
| 5 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 6 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |
| 7 | Partial Opioid Agonist [EPC] | 10 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |